Professor David Goldstein

McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB, 2019, 'Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-019-04680-w

Lim BT; Butow P; Mills J; Miller A; Pearce A; Goldstein D, 2019, 'Challenges and perceived unmet needs of Chinese migrants affected by cancer: Focus group findings', Journal of Psychosocial Oncology, vol. 37, pp. 383 - 397, http://dx.doi.org/10.1080/07347332.2018.1551261

Sclafani F; Hesselberg G; Thompson SR; Truskett P; Haghighi K; Rao S; Goldstein D, 2019, 'Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review', Journal of Surgical Oncology, vol. 119, pp. 489 - 496, http://dx.doi.org/10.1002/jso.25320

Livni L; Lees JG; Barkl-Luke ME; Goldstein D; Moalem-Taylor G, 2019, 'Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture', Neuroscience Letters, vol. 694, pp. 14 - 19, http://dx.doi.org/10.1016/j.neulet.2018.11.016

Maharaj AD; Ioannou L; Croagh D; Zalcberg J; Neale RE; Goldstein D; Merrett N; Kench JG; White K; Pilgrim CHC, 2019, 'Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus', HPB, vol. 21, pp. 444 - 455, http://dx.doi.org/10.1016/j.hpb.2018.08.016

Tie J; Cohen JD; Wang Y; Li L; Christie M; Simons K; Elsaleh H; Kosmider S; Wong R; Yip D, 2019, 'Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: A prospective biomarker study', Gut, vol. 68, pp. 663 - 671, http://dx.doi.org/10.1136/gutjnl-2017-315852

Kaur R; Meiser B; Ziliacus E; Wong WKT; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P, 2018, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-018-4507-4

Shitara K; Özgüroğlu M; Bang YJ; Di Bartolomeo M; Mandalà M; Ryu MH; Fornaro L; Olesiński T; Caglevic C; Chung HC, 2018, 'Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial', The Lancet, vol. 392, pp. 123 - 133, http://dx.doi.org/10.1016/S0140-6736(18)31257-1

Chiorean EG; Von Hoff D; Wan Y; Margunato-Debay S; Botteman M; Goldstein D, 2018, 'Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer', Cancer Management and Research, vol. 10, pp. 1389 - 1396, http://dx.doi.org/10.2147/CMAR.S163475

Battaglini E; Park SB; Barnes EH; Goldstein D, 2018, 'A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy', Contemporary Clinical Trials, vol. 70, pp. 135 - 138, http://dx.doi.org/10.1016/j.cct.2018.04.011

Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4366-x

Wang X; Goldstein D; Crowe PJ; Yang JL, 2018, 'Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines', International Journal of Oncology, vol. 52, pp. 2143 - 2154, http://dx.doi.org/10.3892/ijo.2018.4337

Dumbrava MI; Burmeister EA; Wyld D; Goldstein D; O'Connell DL; Beesley VL; Gooden HM; Janda M; Jordan SJ; Merrett ND, 2018, 'Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 326 - 336, http://dx.doi.org/10.1111/ajco.12862

Chin V; Nagrial A; Sjoquist K; O'Connor CA; Chantrill L; Biankin AV; Scholten RJPM; Yip D, 2018, 'Chemotherapy and radiotherapy for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, vol. 2018, http://dx.doi.org/10.1002/14651858.CD011044.pub2

Feather CE; Lees JG; Makker PGS; Goldstein D; Kwok JB; Moalem-Taylor G; Polly P, 2018, 'Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice', Muscle and Nerve, vol. 57, pp. 650 - 658, http://dx.doi.org/10.1002/mus.25966

Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR, 2018, 'Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer', British Journal of Cancer, vol. 118, pp. 947 - 954, http://dx.doi.org/10.1038/s41416-018-0004-2

Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR, 2018, 'Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemothera', British Journal of Cancer, vol. 118, pp. 1084 - 1088, http://dx.doi.org/10.1038/s41416-018-0005-1

Thompson SR; Lee ISY; Carroll S; Bishop S; Douglas P; Lam F; Brown C; Williams J; Goldstein D, 2018, 'Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?', ANZ Journal of Surgery, vol. 88, pp. 870 - 875, http://dx.doi.org/10.1111/ans.14398

ter Veer E; van Rijssen LB; Besselink MG; Mali RMA; Berlin JD; Boeck S; Bonnetain F; Chau I; Conroy T; Van Cutsem E, 2018, 'Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease', The Lancet Oncology, vol. 19, pp. e151 - e160, http://dx.doi.org/10.1016/S1470-2045(18)30098-6

Payne M; Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley VL; Gooden H, 2018, 'Biliary Stenting in Patients with Pancreatic Cancer: Results from a Population-Based Cohort Study', Pancreas, vol. 47, pp. 80 - 86, http://dx.doi.org/10.1097/MPA.0000000000000960

Clifford BK; Mizrahi D; Sandler CX; Barry BK; Simar D; Wakefield CE; Goldstein D, 2018, 'Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review', Supportive Care in Cancer, vol. 26, pp. 685 - 700, http://dx.doi.org/10.1007/s00520-017-3964-5

Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. e512 - e520, http://dx.doi.org/10.1111/ajco.12815

Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, vol. 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968

Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Kissane DW; Hale S; Perry A, 2018, 'Perspectives of oncology nurses and oncologists regarding barriers to working with patients from a minority background: Systemic issues and working with interpreters', European Journal of Cancer Care, vol. 27, http://dx.doi.org/10.1111/ecc.12758

Martin AJ; Gibbs E; Sjoquist K; Pavlakis N; Simes J; Price T; Shannon J; Gill S; Jain V; Liu G, 2018, 'Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma', Gastric Cancer, vol. 21, pp. 473 - 480, http://dx.doi.org/10.1007/s10120-017-0754-1

Beesley VL; Janda M; Burmeister EA; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Wyld DK; Chan RJ; Young JM, 2018, 'Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes', Palliative and Supportive Care, vol. 16, pp. 534 - 543, http://dx.doi.org/10.1017/S1478951517000608

Goldstein D; Lemech C; Valle J, 2017, 'New molecular and immunotherapeutic approaches in biliary cancer', ESMO Open, vol. 2, http://dx.doi.org/10.1136/esmoopen-2016-000152

Pothula SP; Xu Z; Goldstein D; Merrett N; Pirola RC; Wilson JS; Apte MV, 2017, 'Targeting the HGF/c-MET pathway: Stromal remodelling in pancreatic cancer', Oncotarget, vol. 8, pp. 76722 - 76739, http://dx.doi.org/10.18632/oncotarget.20822

Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ, 2017, 'Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international facult', Expert Review of Anticancer Therapy, vol. 17, pp. 951 - 964, http://dx.doi.org/10.1080/14737140.2017.1369882

Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM, 2017, 'Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue', Journal of Pain and Symptom Management, vol. 54, pp. 74 - 84, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015

McNamara MG; Bridgewater J; Lopes A; Wasan H; Malka D; Jensen LH; Okusaka T; Knox JJ; Wagner D; Cunningham D, 2017, 'Systemic therapy in younger and elderly patients with advanced biliary cancer: Sub-analysis of ABC-02 and twelve other prospective trials', BMC Cancer, vol. 17, http://dx.doi.org/10.1186/s12885-017-3266-9

Pang TCY; Xu Z; Pothula S; Becker T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2017, 'Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research', Carcinogenesis, vol. 38, pp. 588 - 591, http://dx.doi.org/10.1093/carcin/bgx030

Yang JL; Gupta RD; Goldstein D; Crowe PJ, 2017, 'Significance of phosphorylated epidermal growth factor receptor and its signal transducers in human soft tissue sarcoma', International Journal of Molecular Sciences, vol. 18, http://dx.doi.org/10.3390/ijms18061159

Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, vol. 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009

McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, vol. 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y

Tang M; Goldstein D, 2017, 'The role of chemotherapy in gastric cancer-related microangiopathic haemolytic anaemia', Journal of Gastrointestinal Oncology, vol. 8, pp. E10 - E15, http://dx.doi.org/10.21037/jgo.2016.11.14

Hyatt A; Lipson-Smith R; Schofield P; Gough K; Sze M; Aldridge L; Goldstein D; Jefford M; Bell ML; Butow P, 2017, 'Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients', Health Expectations, vol. 20, pp. 886 - 895, http://dx.doi.org/10.1111/hex.12529

Chan DL; Sjoquist KM; Goldstein D; Price TJ; Martin AJ; Bang YJ; Kang YK; Pavlakis N, 2017, 'The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0172307

Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P, 2017, 'MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity', Oncotarget, vol. 8, pp. 9216 - 9229, http://dx.doi.org/10.18632/oncotarget.13985

Lim BT; Butow P; Mills J; Miller A; Goldstein D, 2017, 'Information needs of the Chinese community affected by cancer: A systematic review', Psycho-Oncology, vol. 26, pp. 1433 - 1443, http://dx.doi.org/10.1002/pon.4347

Janda M; Neale RE; Klein K; O'Connell DL; Gooden H; Goldstein D; Merrett ND; Wyld DK; Rowlands IJ; Beesley VL, 2017, 'Anxiety, depression and quality of life in people with pancreatic cancer and their carers', Pancreatology, vol. 17, pp. 321 - 327, http://dx.doi.org/10.1016/j.pan.2017.01.008

Kunzmann V; Ramanathan RK; Goldstein D; Liu H; Ferrara S; Lu B; Renschler MF; Von Hoff DD, 2017, 'Tumor reduction in primary andmetastatic pancreatic cancer lesions with nab-paclitaxel and gemcitabine: An exploratory analysis from a phase 3 study', Pancreas, vol. 46, pp. 203 - 208, http://dx.doi.org/10.1097/MPA.0000000000000742

Makker PGS; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0170814

Lees JG; Makker PGS; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy', European Journal of Cancer, vol. 73, pp. 22 - 29, http://dx.doi.org/10.1016/j.ejca.2016.12.006

Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Goldstein D; Hale S; Perry A, 2017, 'Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals', European Journal of Oncology Nursing, vol. 26, pp. 83 - 90, http://dx.doi.org/10.1016/j.ejon.2016.12.001

Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2017, 'Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review', Asia-Pacific Journal of Clinical Oncology, vol. 13, pp. e291 - e297, http://dx.doi.org/10.1111/ajco.12638

Ritchie GE; Fernando M; Goldstein D, 2017, 'Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review', Cancer Chemotherapy and Pharmacology, vol. 79, http://dx.doi.org/10.1007/s00280-016-3123-6

Gormly KL; Coscia C; Wells T; Tebbutt N; Harvey JA; Wilson K; Schmoll HJ; Price T; Price T; Hruby G, 2016, 'MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial', Journal of Medical Imaging and Radiation Oncology, vol. 60, pp. 607 - 615, http://dx.doi.org/10.1111/1754-9485.12493

Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus', MEDICAL JOURNAL OF AUSTRALIA, vol. 204, pp. 419 - +, http://dx.doi.org/10.5694/mja16.00061

de Souza P; Chua W; Clarke S; Goldstein D; Lee C, 2016, 'Inflammatory Markers Have a Role in Renal Cell Carcinoma Prognosis', European Urology Focus, vol. 2, pp. 341 - 342, http://dx.doi.org/10.1016/j.euf.2016.04.007

Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia (United States), vol. 18, pp. 753 - 764, http://dx.doi.org/10.1016/j.neo.2016.10.011

Yang JL; Lim HJ; Wang X; Crowe PJ; Goldstein D, 2016, 'Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines', Anticancer research, vol. 36, pp. 5765 - 5772, http://dx.doi.org/10.21873/anticanres.11160

Huguet F; Goldstein D; Hammel P, 2016, 'Radiation therapy deviations in trial of locally advanced pancreatic cancer: In Reply', JAMA - Journal of the American Medical Association, vol. 316, pp. 1409 - 1410, http://dx.doi.org/10.1001/jama.2016.9781

Scheithauer W; Ramanathan RK; Moore M; Macarulla T; Goldstein D; Hammel P; Kunzmann V; Liu H; McGovern D; Romano A, 2016, 'Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: Phase III MPACT trial', Journal of Gastrointestinal Oncology, vol. 7, pp. 469 - 478, http://dx.doi.org/10.21037/jgo.2016.01.03

Burmeister EA; O’Connell DL; Jordan SJ; Goldstein D; Merrett N; Wyld DK; Beesley VL; Gooden HM; Janda M; Neale RE, 2016, 'Factors associated with quality of care for patients with pancreatic cancer in Australia', Medical Journal of Australia, vol. 205, pp. 459 - 465, http://dx.doi.org/10.5694/mja16.00567

Vickers MM; Lee C; Tu D; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H; O'Callaghan CJ; Jonker DJ, 2016, 'Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3', Pancreatology, vol. 16, pp. 1106 - 1112, http://dx.doi.org/10.1016/j.pan.2016.08.013

Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: The AGITG Pancreatic Cancer Workshop consensus', Medical Journal of Australia, vol. 204, pp. 419 - 422.e1, http://dx.doi.org/10.5694/mja16.00061

He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

Burmeister EA; Jordan SJ; O’Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Merrett ND; Wyld D; Neale RE, 2016, 'Using a Delphi process to determine optimal care for patients with pancreatic cancer', Asia-Pacific Journal of Clinical Oncology, vol. 12, pp. 105 - 114, http://dx.doi.org/10.1111/ajco.12450

Wang X; Goldstein D; Crowe PJ; Yang JL, 2016, 'Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: A review of the evidence', OncoTargets and Therapy, vol. 9, pp. 5461 - 5473, http://dx.doi.org/10.2147/OTT.S94745

Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA, 2016, 'Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge', Cancer Treatment Reviews, vol. 50, pp. 118 - 128, http://dx.doi.org/10.1016/j.ctrv.2016.09.005

Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Kang YK; Bang YJ; Alcindor T; O'Callaghan CJ; Burnell MJ, 2016, 'Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial', Journal of Clinical Oncology, vol. 34, pp. 2728 - 2735, http://dx.doi.org/10.1200/JCO.2015.65.1901

Wang X; Goldstein D; Crowe P; Yang M; Garrett K; Zeps N; Yang JL, 2016, 'Overcoming resistance of targeted egfr monotherapy by inhibition of stat3 escape pathway in soft tisue sarcoma', Oncotarget, vol. 7, pp. 21496 - 21509, http://dx.doi.org/10.18632/oncotarget.7452

Vernerey D; Huguet F; Vienot A; Goldstein D; Paget-Bailly S; Van Laethem JL; Glimelius B; Artru P; Moore MJ; André T, 2016, 'Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)', British Journal of Cancer, vol. 115, pp. 281 - 289, http://dx.doi.org/10.1038/bjc.2016.212

Chantrill L; Goldstein D, 2016, 'Pancreatic cancer', Cancer Forum, vol. 40, pp. 3 - 5

Chiorean EG; Von Hoff DD; Tabernero J; El-Maraghi R; Ma WW; Reni M; Harris M; Whorf R; Liu H; Li JS, 2016, 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer', British Journal of Cancer, vol. 115, pp. 188 - 194, http://dx.doi.org/10.1038/bjc.2016.185

Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley V; Gooden H; Janda M, 2016, 'Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study', Pancreatology, vol. 16, pp. 873 - 881, http://dx.doi.org/10.1016/j.pan.2016.06.010

Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HTT; Liu J; Sharbeen G; Goldstein D; Davis TP, 2016, 'A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo', Biomacromolecules, vol. 17, pp. 2337 - 2351, http://dx.doi.org/10.1021/acs.biomac.6b00185

Ferraro D; Goldstein D; O'Connell RL; Zalcberg JR; Sjoquist KM; Tebbutt NC; Grimison P; McLachlan S; Lipton LL; Vasey P, 2016, 'TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer', Cancer Chemotherapy and Pharmacology, vol. 78, pp. 361 - 367, http://dx.doi.org/10.1007/s00280-016-3089-4

Hammel P; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Borbath I; Bouché O; Shannon J; André T, 2016, 'Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clin', JAMA - Journal of the American Medical Association, vol. 315, pp. 1844 - 1853, http://dx.doi.org/10.1001/jama.2016.4324

He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

2016, 'Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (Support Care Cancer, 10.1007/s00520-016-3212-4)', Supportive Care in Cancer, vol. 24, pp. 3601 - 3602, http://dx.doi.org/10.1007/s00520-016-3251-x

Waterhouse MA; Burmeister EA; O’Connell DL; Ballard EL; Jordan SJ; Merrett ND; Goldstein D; Wyld D; Janda M; Beesley VL, 2016, 'Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study', Journal of Gastrointestinal Surgery, vol. 20, pp. 1471 - 1481, http://dx.doi.org/10.1007/s11605-016-3157-4

Ramanathan RK; Goldstein D; Korn RL; Arena F; Moore M; Siena S; Teixeira L; Tabernero J; Van Laethem JL; Liu H, 2016, 'Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the', Annals of Oncology, vol. 27, pp. 648 - 653, http://dx.doi.org/10.1093/annonc/mdw020

Chiorean EG; Von Hoff DD; Reni M; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR, 2016, 'CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pan', Annals of Oncology, vol. 27, pp. 654 - 660, http://dx.doi.org/10.1093/annonc/mdw006

Beesley VL; Wockner LF; O’Rourke P; Janda M; Goldstein D; Gooden H; Merrett ND; O’Connell DL; Rowlands IJ; Wyld DK, 2016, 'Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study', Supportive Care in Cancer, vol. 24, pp. 3589 - 3599, http://dx.doi.org/10.1007/s00520-016-3212-4

Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J, 2016, 'Prognostic factors for progression-free and overall survival in advanced biliary tract cancer', Annals of Oncology, vol. 27, pp. 134 - 140, http://dx.doi.org/10.1093/annonc/mdv483

Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV, 2016, 'Hepatocyte growth factor inhibition: A novel therapeutic approach in pancreatic cancer', British Journal of Cancer, vol. 114, pp. 269 - 280, http://dx.doi.org/10.1038/bjc.2015.478

McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B, 2016, 'The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman', European Journal of Cancer, vol. 55, pp. 15 - 26, http://dx.doi.org/10.1016/j.ejca.2015.10.060

Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im SA; Gupta S; Kang YK; Schöffski P; Schuette J; Soulières D, 2016, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial', BMC Cancer, vol. 16, http://dx.doi.org/10.1186/s12885-016-2051-5

Shaw JM; Shepherd HL; Durcinoska I; Butow PN; Liauw W; Goldstein D; Young JM, 2016, 'It’s all good on the surface: care coordination experiences of migrant cancer patients in Australia', Supportive Care in Cancer, vol. 24, pp. 2403 - 2410, http://dx.doi.org/10.1007/s00520-015-3043-8

Goldstein D; Rosenberg JE; Figlin RA; Townsend RR; McCann L; Carpenter C; Pandite L, 2016, 'Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?', European Journal of Cancer, vol. 53, pp. 96 - 104, http://dx.doi.org/10.1016/j.ejca.2015.10.006

O’Callaghan C; Schofield P; Butow P; Nolte L; Price M; Tsintziras S; Sze M; Thein T; Yiu D; Mireskandari S, 2016, '“I might not have cancer if you didn’t mention it”: a qualitative study on information needed by culturally diverse cancer survivors', Supportive Care in Cancer, vol. 24, pp. 409 - 418, http://dx.doi.org/10.1007/s00520-015-2811-9

Goldstein D; Von Hoff DD; Moore M; Greeno E; Tortora G; Ramanathan RK; Macarulla T; Liu H; Pilot R; Ferrara S, 2016, 'Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analy', European Journal of Cancer, vol. 52, pp. 85 - 91, http://dx.doi.org/10.1016/j.ejca.2015.10.017

Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2016, 'Key role of pancreatic stellate cells in pancreatic cancer', Cancer Letters, vol. 381, pp. 194 - 200, http://dx.doi.org/10.1016/j.canlet.2015.10.035

Beesley VL; Janda M; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Rowlands IJ; Wyld D; Neale RE, 2016, 'A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services', Psycho-Oncology, vol. 25, pp. 150 - 157, http://dx.doi.org/10.1002/pon.3887

Apte MV; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS, 2015, 'Pancreatic cancer: The microenvironment needs attention too!', Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], vol. 15, pp. S32 - S38, http://dx.doi.org/10.1016/j.pan.2015.02.013

Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H, 2015, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft', Journal of Clinical Oncology, vol. 33, pp. 4276 - 4283, http://dx.doi.org/10.1200/JCO.2015.62.4304

Donskov F; Michaelson MD; Puzanov I; Davis MP; Bjarnason GA; Motzer RJ; Goldstein D; Lin X; Cohen DP; Wiltshire R, 2015, 'Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients', British Journal of Cancer, vol. 113, pp. 1571 - 1580, http://dx.doi.org/10.1038/bjc.2015.368

Burmeister EA; O'Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Wyld D, 2015, 'Describing patterns of care in pancreatic cancer a population-based study', Pancreas, vol. 44, pp. 1259 - 1265, http://dx.doi.org/10.1097/MPA.0000000000000384

Chandrasegaram MD; Goldstein D; Simes J; Gebski V; Kench JG; Gill AJ; Samra JS; Merrett ND; Richardson AJ; Barbour AP, 2015, 'Meta-analysis of radical resection rates and margin assessment in pancreatic cancer', British Journal of Surgery, vol. 102, pp. 1459 - 1472, http://dx.doi.org/10.1002/bjs.9892

Vajdic CM; Goldstein D, 2015, 'Cancer of unknown primary site', Australian Family Physician, vol. 44, pp. 640 - 643

Tebbutt N; Kotasek D; Burris HA; Schwartzberg LS; Hurwitz H; Stephenson J; Warner DJ; Chen L; Hsu CP; Goldstein D, 2015, 'Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, vol. 75, pp. 993 - 1004, http://dx.doi.org/10.1007/s00280-015-2694-y

Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a rando', BMC Cancer, vol. 15, http://dx.doi.org/10.1186/s12885-015-1498-0

Davis ID; Long A; Yip S; Espinoza D; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N; Azad A, 2015, 'EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma', Annals of Oncology, vol. 26, pp. 1118 - 1123, http://dx.doi.org/10.1093/annonc/mdv078

Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L, 2015, 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial', Journal of the National Cancer Institute, vol. 107, http://dx.doi.org/10.1093/jnci/dju413

Sze M; Butow P; Bell M; Vaccaro L; Dong S; Eisenbruch M; Jefford M; Girgis A; King M; McGrane J, 2015, 'Migrant health in cancer: Outcome disparities and the determinant role of migrant-specific variables', Oncologist, vol. 20, pp. 523 - 531, http://dx.doi.org/10.1634/theoncologist.2014-0274

Sharbeen G; McCarroll J; Goldstein D; Phillips PA, 2015, 'Exploiting base excision repair to improve therapeutic approaches for pancreatic cancer.', Front Nutr, vol. 2, pp. 10, http://dx.doi.org/10.3389/fnut.2015.00010

Pantaleo MA; Lolli C; Nannini M; Astolfi A; Indio V; Saponara M; Urbini M; La Rovere S; Gill A; Goldstein D, 2015, 'Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations', Genetics in Medicine, vol. 17, pp. 391 - 395, http://dx.doi.org/10.1038/gim.2014.115

Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; McArthur G, 2015, 'Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib', European Journal of Cancer, vol. 51, pp. 852 - 860, http://dx.doi.org/10.1016/j.ejca.2015.02.015

Chan DL; Goldstein D; Zalcberg JR, 2015, 'Neuroendocrine tumours - Models for rare tumour management', Cancer Forum, vol. 39, pp. 13 - 16

Murphy C; Sabesan S; Steer C; Yates P; Booms A; Jones V; Simpson A; Clarke K; Eek R; Ashley D, 2015, 'Oncology service initiatives and research in regional Australia', Australian Journal of Rural Health, vol. 23, pp. 40 - 48, http://dx.doi.org/10.1111/ajr.12173

Tabernero J; Gabrielachiorean E; Infante JR; Hingorani SR; Ganju V; Weekes C; Scheithauer W; Ramanathan RK; Goldstein D; Penenberg DN, 2015, 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Oncologist, vol. 20, pp. 143 - 150, http://dx.doi.org/10.1634/theoncologist.2014-0394

McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M, 2015, 'βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer', Oncotarget, vol. 6, pp. 2235 - 2249, http://dx.doi.org/10.18632/oncotarget.2946

Wang X; Batty KM; Crowe PJ; Goldstein D; Yang J-L, 2015, 'The Potential of panHER Inhibition in Cancer.', Front Oncol, vol. 5, pp. 2, http://dx.doi.org/10.3389/fonc.2015.00002

Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D, 2014, 'Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study', Journal of Clinical Oncology, vol. 32, pp. 504 - 512, http://dx.doi.org/10.1200/JCO.2013.50.7657

McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, vol. 23, pp. 2819 - 2830, http://dx.doi.org/10.1007/s11136-014-0717-5

Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, vol. 14, http://dx.doi.org/10.1186/1471-2407-14-993

Davis ID; Long A; Martin A; Espinoza D; Yip S; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N, 2014, 'EVERSUN: A PHASE 2 TRIAL OF EVEROLIMUS ALTERNATING WITH SUNITINIB AS FIRST-LINE THERAPY FOR ADVANCED RENAL CELL CARCINOMA (ANZUP TRIAL 0901)', EUROPEAN JOURNAL OF CANCER, vol. 50, pp. E68 - E69, http://dx.doi.org/10.1016/j.ejca.2014.03.255

Jefford M; Nolte L; Tsintziras S; Butow P; Sze M; Yiu D; Schofield P; Goldstein D; Price M, 2014, 'HOW IS POST-TREATMENT SURVIVORSHIP CONCEPTUALISED BY PEOPLE FROM DIFFERENT CULTURAL GROUPS?', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 10, pp. 158 - 158, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700480&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Wang X; Goldstein D; Crowe PJ; Yang JL, 2014, 'Impact of STAT3 inhibition on survival of osteosarcoma cell lines', Anticancer Research, vol. 34, pp. 6537 - 6545

McGrane J; Butow P; Sze M; Eisenbruch M; Goldstein D; King M, 2014, 'Assessing the Invariance of a Culturally Competent Multi-lingual Unmet Needs Survey for Immigrant and Australian-born Cancer Patients: A Rasch Analysis', PSYCHO-ONCOLOGY, vol. 23, pp. 153 - 153, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344003700220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS, 2014, 'The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: Anti-angiogenic implications in pancreatic cancer', Carcinogenesis, vol. 35, http://dx.doi.org/10.1093/carcin/bgu122

Goldstein D; Bell ML; Butow P; Sze M; Vaccaro L; Dong S; Liauw W; Hui R; Tattersall M; Ng W, 2014, 'Immigrants' perceptions of the quality of their cancer care: An Australian comparative study, identifying potentially modifiable factors', Annals of Oncology, vol. 25, pp. 1643 - 1649, http://dx.doi.org/10.1093/annonc/mdu182

Bennett BK; Goldstein D; Chen M; Davenport TA; Vollmer-Conna U; Scott EM; Hickie IB; Lloyd AR, 2014, 'Characterization of fatigue states in medicine and psychiatry by structured interview', Psychosomatic Medicine, vol. 76, pp. 379 - 388, http://dx.doi.org/10.1097/PSY.0000000000000061

McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, http://dx.doi.org/10.1007/s11136-014-0717-5

McCarroll JA; Naim S; Sharbeen G; Russia N; Lee J; Kavallaris M; Goldstein D; Phillips PA, 2014, 'Role of pancreatic stellate cells in chemoresistance in pancreatic cancer', Frontiers in Physiology, vol. 5 APR, http://dx.doi.org/10.3389/fphys.2014.00141

Von Hoff DD; Goldstein D; Renschler MF, 2014, 'The authors reply', New England Journal of Medicine, vol. 370, pp. 479 - 480, http://dx.doi.org/10.1056/NEJMc1314761

McCarroll J; Teo J; Boyer C; Goldstein D; Kavallaris M; Phillips PA, 2014, 'Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer', Frontiers in Physiology, vol. 5 JAN, http://dx.doi.org/10.3389/fphys.2014.00002

Greenhalf W; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Lamb RF; Garner E; Campbell F; MacKey JR; Costello E, 2014, 'Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial', Journal of the National Cancer Institute, vol. 106, http://dx.doi.org/10.1093/jnci/djt347

Hillman RJ; Gunathilake MP; Mchugh L; Jin F; Garland SM; Stevens M; Tabrizi SN; Kumaradevan N; Lemech C; Goldstein D, 2014, 'Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.28730

Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; André T; Mineur L, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final resul', J Clin Oncol, vol. 31, pp. LBA4003, http://dx.doi.org/10.1200/jco.2013.31.18_suppl.lba4003

Tan CJ; Yang JL; Crowe P; Goldstein D, 2013, 'Targeted therapy in soft tissue sarcoma-A novel direction in therapeutics', Chinese Clinical Oncology, vol. 2, http://dx.doi.org/10.3978/j.issn.2304-3865.2013.08.01

Wang X; Goldstein D; Crowe P; Yang J, 2013, 'S3I-201, a novel STAT3 inhibitor, inhibits growth of human soft tissue sarcoma cell lines', World Journal of Cancer Research, http://dx.doi.org/10.1166/wjcr.2013.1005

Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N, 2013, 'Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer', International Journal of Radiation Oncology Biology Physics, vol. 85, pp. 157 - 162, http://dx.doi.org/10.1016/j.ijrobp.2012.03.003

Shaw J; Butow P; Sze M; Young J; Goldstein D, 2013, 'Reducing disparity in outcomes for immigrants with cancer: A qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention', Supportive Care in Cancer, vol. 21, pp. 2297 - 2301, http://dx.doi.org/10.1007/s00520-013-1786-7

Butow PN; Sze M; Eisenbruch M; Bell ML; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J, 2013, 'Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients', Patient Education and Counseling, vol. 92, pp. 246 - 252, http://dx.doi.org/10.1016/j.pec.2013.03.006

Grimison P; Phillips F; Butow P; White K; Yip D; Sardelic F; Underhill C; Tse R; Simes R; Turley K, 2013, 'Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals', Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 226 - 238, http://dx.doi.org/10.1111/ajco.12014

Von Hoff DD; Ervin T; Arena FP; Chiorean EG; Infante J; Moore M; Seay T; Tjulandin SA; Ma WW; Saleh MN, 2013, 'Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine', New England Journal of Medicine, vol. 369, pp. 1691 - 1703, http://dx.doi.org/10.1056/NEJMoa1304369

Bell ML; Butow PN; Goldstein D, 2013, 'Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors', Quality of Life Research, vol. 22, pp. 2757 - 2760, http://dx.doi.org/10.1007/s11136-013-0392-y

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204

Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken NRC; Wyld DK; Abdi EA; Glasgow A; Beale PJ, 2013, 'The median informs the message: Accuracy of individualized scenarios for survival time based on oncologists' estimates', Journal of Clinical Oncology, vol. 31, pp. 3565 - 3571, http://dx.doi.org/10.1200/JCO.2012.44.7821

Ackland S; Goldstein D; McJannett M, 2013, 'Forty years of COSA - Contributions to oncology teaching and research', Cancer Forum, vol. 37, pp. 238 - 242

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, vol. 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204

Chou A; Waddell N; Cowley MJ; Gill AJ; Chang DK; Patch AM; Nones K; Wu J; Pinese M; Johns AL, 2013, 'Clinical and molecular characterization of HER2 amplified-pancreatic cancer', Genome Medicine, vol. 5, http://dx.doi.org/10.1186/gm482

Butow PN; Aldridge L; Bell ML; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-Beri P, 2013, 'Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study', European Journal of Cancer, vol. 49, pp. 1948 - 1956, http://dx.doi.org/10.1016/j.ejca.2013.01.011

Butow PN; Bell ML; Aldridge LJ; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal PS, 2013, 'Unmet needs in immigrant cancer survivors: A cross-sectional population-based study', Supportive Care in Cancer, vol. 21, pp. 2509 - 2520, http://dx.doi.org/10.1007/s00520-013-1819-2

Tan K; Yang J-L; Goldstein D; Crowe P, 2013, 'Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis', Journal of Cancer Research and Clinical Oncology, pp. 1 - 11, http://dx.doi.org/10.1007/s00432-013-1482-5

Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, vol. 10, pp. 2435 - 2444, http://dx.doi.org/10.1021/mp400049e

Grünwald V; Karakiewicz PI; Bavbek SE; Miller K; Machiels JP; Lee SH; Larkin J; Bono P; Rha SY; Castellano D, 2012, 'An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor', European Journal of Cancer, vol. 48, pp. 324 - 332, http://dx.doi.org/10.1016/j.ejca.2011.06.054

Butow P; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; Goldstein D; King MT, 2012, 'Inferior quality of life and psychological well-being in immigrant cancer survivors', QUALITY OF LIFE RESEARCH, vol. 21, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209358900132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow PN; Phillips F; Schweder J; White K; Underhill C; Goldstein D, 2012, 'Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: A systematic review', Supportive Care in Cancer, vol. 20, pp. 1 - 22, http://dx.doi.org/10.1007/s00520-011-1270-1

Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Mark Jeffrey G; Tebbutt NC; Buck M; Lowenthal RM, 2012, 'Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analys', European Journal of Cancer, vol. 48, pp. 407, http://dx.doi.org/10.1016/j.ejca.2011.12.001

Mitchison D; Butow P; Sze M; Aldridge L; Hui R; Vardy J; Eisenbruch M; Iedema R; Goldstein D, 2012, 'Prognostic communication preferences of migrant patients and their relatives', Psycho-Oncology, vol. 21, pp. 496 - 504, http://dx.doi.org/10.1002/pon.1923

Dumont AG; Rink L; Godwin AK; Miettinen M; Joensuu H; Strosberg JR; Gronchi A; Corless CL; Goldstein D; Rubin BP, 2012, 'A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): Case series of 28 patients', Annals of Oncology, vol. 23, pp. 1335 - 1340, http://dx.doi.org/10.1093/annonc/mdr442

Butow PN; Lobb E; Jefford M; Goldstein D; Eisenbruch M; Girgis A; King M; Sze M; Aldridge L; Schofield P, 2012, 'A bridge between cultures: Interpreters' perspectives of consultations with migrant oncology patients', Supportive Care in Cancer, vol. 20, pp. 235 - 244, http://dx.doi.org/10.1007/s00520-010-1046-z

Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA, 2012, 'Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04', Journal of Clinical Oncology, vol. 30, pp. 3827 - 3833, http://dx.doi.org/10.1200/JCO.2012.42.9597

Goldstein D; Bennett BK; Webber K; Boyle F; De Souza PL; Wilcken NRC; Scott EM; Toppler R; Murie P; O'Malley L, 2012, 'Cancer-related fatigue in women with breast cancer: Outcomes of a 5-year prospective cohort study', Journal of Clinical Oncology, vol. 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148

Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, vol. 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269

Goldstein D; Spry N; Cummins MM; Brown C; Van Hazel GA; Carroll S; Selva-Nayagam S; Borg M; Ackland SP; Wratten C, 2012, 'The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer', British Journal of Cancer, vol. 106, pp. 61 - 69, http://dx.doi.org/10.1038/bjc.2011.526

Bennett BK; Park SB; Lin CSY; Friedlander ML; Kiernan MC; Goldstein D, 2012, 'Impact of oxaliplatin-induced neuropathy: A patient perspective', Supportive Care in Cancer, vol. 20, pp. 2959 - 2967, http://dx.doi.org/10.1007/s00520-012-1428-5

Demetri GD; Garrett CR; Schöffski P; Shah MH; Verweij J; Leyvraz S; Hurwitz HI; Pousa AL; Le Cesne A; Goldstein D, 2012, 'Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure', Clinical Cancer Research, vol. 18, pp. 3170 - 3179, http://dx.doi.org/10.1158/1078-0432.CCR-11-3005

Cameron BA; Bennett B; Li H; Boyle F; Desouza P; Wilcken N; Friedlander M; Goldstein D; Lloyd AR, 2012, 'Post-cancer fatigue is not associated with immune activation or altered cytokine production', Annals of Oncology, vol. 23, pp. 2890 - 2895, http://dx.doi.org/10.1093/annonc/mds108

Wang X; Crowe PJ; Goldstein D; Yang JL, 2012, 'STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (Review)', International Journal of Oncology, vol. 41, pp. 1181 - 1191, http://dx.doi.org/10.3892/ijo.2012.1568

Goldstein D; Lee C; Tracey E; Cook-Yarborough C; Lord S, 2011, 'Validating innovation: A population-based study of gastrointestinal stromal tumors (GIST) to estimate the survival benefit of imatinib.', J Clin Oncol, vol. 29, pp. 10060, http://www.ncbi.nlm.nih.gov/pubmed/28021288

Webber K; Mok K; Bennett BK; Juraskova I; Goldstein D; Friedlander M; Lloyd AR; FOLCAN study group, 2011, 'Cancer-related fatigue and sexual functioning in women with early breast cancer: Is there a link?', J Clin Oncol, vol. 29, pp. 9072, http://www.ncbi.nlm.nih.gov/pubmed/28021533

Yang JL; DasGupta R; Hopkins A; Luk F; Goldstein D; Crowe P, 2011, 'Significance of IGF-1R and Its signaling pathways in human sarcoma', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-4416

Arun SJ; Xu Z; Fiala-Beer E; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-LB-395

Goldstein D; Gainford MC; Brown C; Tebbutt N; Ackland SP; Van Hazel G; Jefford M; Abdi E; Selva-Nayagam S; Gebski V, 2011, 'Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, vol. 67, pp. 519 - 525, http://dx.doi.org/10.1007/s00280-010-1351-8

Wirth A; Grigg A; Wolf M; Goldstein D; Johnson C; Davis S; Dutu G; Kypreos P; Smith C; Kneebone A, 2011, 'Risk and response adapted therapy for early stage Hodgkin lymphoma: A prospective multicenter study of the Australasian Leukaemia and lymphoma group/trans-tasman radiation oncology group', Leukemia and Lymphoma, vol. 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155

Leighl NB; Shepherd HL; Butow PN; Clarke SJ; McJannett M; Beale PJ; Wilcken NRC; Moore MJ; Chen EX; Goldstein D, 2011, 'Supporting treatment decision making in advanced cancer: A randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy', Journal of Clinical Oncology, vol. 29, pp. 2077 - 2084, http://dx.doi.org/10.1200/JCO.2010.32.0754

Butow PN; Goldstein D; Bell ML; Sze M; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J, 2011, 'Interpretation in consultations with immigrant patients with cancer: How accurate is it?', Journal of Clinical Oncology, vol. 29, pp. 2801 - 2807, http://dx.doi.org/10.1200/JCO.2010.34.3335

Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Jeffrey GM; Tebbutt NC; Buck M; Lowenthal RM, 2011, 'Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis', European Journal of Cancer, vol. 47, pp. 1826 - 1836, http://dx.doi.org/10.1016/j.ejca.2011.04.024

Peng J; Shi D; Goodman KA; Goldstein D; Xiao C; Guan Z; Cai S, 2011, 'Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29', Radiation Oncology, vol. 6, http://dx.doi.org/10.1186/1748-717X-6-93

Butow P; Bell M; Goldstein D; Sze M; Aldridge L; Abdo S; Mikhail M; Dong S; Iedema R; Ashgari R, 2011, 'Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters', Patient Education and Counseling, vol. 84, pp. 398 - 405, http://dx.doi.org/10.1016/j.pec.2011.01.035

Zhi J; Chen E; Major P; Burns I; Robinson B; McKendrick J; Rittweger K; Abt M; Goldstein D, 2011, 'A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, vol. 68, pp. 1199 - 1206, http://dx.doi.org/10.1007/s00280-011-1606-z

Tebbutt NC; Murphy F; Zannino D; Wilson K; Cummins MM; Abdi E; Strickland AH; Lowenthal RM; Marx G; Karapetis C, 2011, 'Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab', Annals of Oncology, vol. 22, pp. 1834 - 1838, http://dx.doi.org/10.1093/annonc/mdq702

Butow PN; Sze M; Dugal-Beri P; Mikhail M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Goldstein D, 2011, 'From inside the bubble: Migrants' perceptions of communication with the cancer team', Supportive Care in Cancer, vol. 19, pp. 281 - 290, http://dx.doi.org/10.1007/s00520-010-0817-x

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis.', Lancet Oncol, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1

Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis', The Lancet Oncology, vol. 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1

Webber K; Mok K; Bennett B; Lloyd AR; Friedlander M; Juraskova I; Goldstein D, 2011, 'If I am in the mood, I enjoy it: An exploration of cancer-related fatigue and sexual functioning in women with breast cancer', Oncologist, vol. 16, pp. 1333 - 1344, http://dx.doi.org/10.1634/theoncologist.2011-0100

Webber K; Cooper A; Kleiven H; Yip D; Goldstein D, 2011, 'Management of metastatic renal cell carcinoma in the era of targeted therapies', Internal Medicine Journal, vol. 41, pp. 594 - 605, http://dx.doi.org/10.1111/j.1445-5994.2011.02540.x

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, vol. 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'Dose effects of oxaliplatin on persistent and transient Na⁺ conductances and the development of neurotoxicity', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0018469

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'Long-term neuropathy after oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, vol. 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248

Park SB; Goldstein D; Lin CSY; Krishnan AV; Friedlander ML; Kiernan MC, 2011, 'Neuroprotection for oxaliplatin-induced neurotoxicity: What happened to objective assessment?', Journal of Clinical Oncology, vol. 29, http://dx.doi.org/10.1200/JCO.2011.34.8227

Wirth A; Grigg A; Wolf M; Goldstein D; Johnson C; Davis S; Dutu G; Kypreos P; Smith C; Kneebone A, 2011, 'Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, vol. 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155

Goldstein D; Gainford M; Brown C; Tebbutt N; Ackland S; Van Hazel GA; Jefford M; Abdi E; Gebski V; Miller D, 2011, 'Fixed dose rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, vol. 16, pp. 519 - 519

Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723

Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C, 2010, 'Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial', JAMA - Journal of the American Medical Association, vol. 304, pp. 1073 - 1081, http://dx.doi.org/10.1001/jama.2010.1275

Chua YJ; Michael M; Zalcberg JR; Hicks RJ; Goldstein D; Liauw W; Price T, 2010, 'Antitumor effect of somatostatin analogs in neuroendocrine tumors', Journal of Clinical Oncology, vol. 28, http://dx.doi.org/10.1200/JCO.2009.26.0612

Blinman P; Duric V; Nowak AK; Beale P; Clarke S; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M, 2010, 'Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?', European Journal of Cancer, vol. 46, pp. 1800 - 1807, http://dx.doi.org/10.1016/j.ejca.2009.12.032

Koczwara B; Francis K; Marine F; Goldstein D; Underhill C; Olver I, 2010, 'Reaching further with online education? the development of an effective online program in palliative oncology', Journal of Cancer Education, vol. 25, pp. 317 - 323, http://dx.doi.org/10.1007/s13187-009-0037-6

Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, vol. 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047

Lovell MR; Forder PM; Stockler MR; Butow P; Briganti EM; Chye R; Goldstein D; Boyle FM, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain.', J Pain Symptom Manage, vol. 40, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013

Lovell MR; Forder PM; Stockler MR; Butow P; Briganti EM; Chye R; Goldstein D; Boyle FM, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, vol. 40, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013

Sjoquist KM; Goldstein D; Bester L, 2010, 'A serious complication of selected internal radiation therapy: Case report and literature review', Oncologist, vol. 15, pp. 830 - 835, http://dx.doi.org/10.1634/theoncologist.2010-0074

Gill AJ; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias V; Samra J; Goldstein D; Smith C, 2010, 'Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types', American Journal of Surgical Pathology, vol. 34, pp. 636 - 644, http://dx.doi.org/10.1097/PAS.0b013e3181d6150d

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, 'Oxaliplatin-Induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity', Oncology, vol. 77, pp. 342 - 348, http://dx.doi.org/10.1159/000265940

Xu Z; Vonlaufen A; Phillips PA; Fiala-Beer E; Zhang X; Yang L; Biankin AV; Goldstein D; Pirola RC; Wilson JS, 2010, 'Role of pancreatic stellate cells in pancreatic cancer metastasis', American Journal of Pathology, vol. 177, pp. 2585 - 2596, http://dx.doi.org/10.2353/ajpath.2010.090899

Goldstein D; Harris C; Harris C, 2010, 'Tamoxifen use in retroperitoneal fibrosis, case report and review of the literature', Internal Medicine Journal, vol. 40, pp. e5 - e7

Goldstein D; Ackland S; Van Hazel GA; Jefford M; Shannon JF; Gainford M; Brown C; Abdi E; Miller D; Gebski V, 2010, 'Optimising the benefit: a phase II trial of Gemcitabine in fixed dose rate infusion combined with Cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology

Goldstein D; van Hazel G; Selva-Nayagam S; Ackland S; Shapiro J; Carroll S; Cummins M; Brown C; Simes RJ; Spry N, 2009, 'GOFURTGO trial (GFG): An AGITG multicenter phase II study of fixed dose rate gemcitabine-oxaliplatin (Gem-Ox) integrated with concomitant 5FU and 3-D conformal radiotherapy (5FU-3DRT) for the treatmen', J Clin Oncol, vol. 27, pp. 4616, http://www.ncbi.nlm.nih.gov/pubmed/27964183

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2009, 'WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online)

Phillips P; Chow MW; Vonlaufen A; Xu Z; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression.', CANCER RESEARCH, vol. 69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', CANCER RESEARCH, vol. 69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lee CK; Hadley A; Desilva K; Smith G; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, vol. 7, http://dx.doi.org/10.1186/1477-7819-7-8

Steer CB; Marx GM; Singhal N; McJannett M; Goldstein D; Prowse R, 2009, 'Cancer in older people: A tale of two disciplines', Internal Medicine Journal, vol. 39, pp. 771 - 775, http://dx.doi.org/10.1111/j.1445-5994.2009.02056.x

Lee CK; Hadley A; Desilva K; Smith G; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis.', World J Surg Oncol, vol. 7, pp. 8, http://dx.doi.org/10.1186/1477-7819-7-8

Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Normal Pancreatic Stellate Cells Facilitate Pancreatic Cancer Progression, Exhibit Transendothelial Migration and Accompany Cancer Cells to Distant Metastatic Sites', PANCREAS, vol. 38, pp. 1062 - 1062, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271225300403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Chua W; Goldstein D; Lee CK; Dhillon H; Michael M; Mitchell P; Clarke SJ; Iacopetta B, 2009, 'Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer', British Journal of Cancer, vol. 101, pp. 998 - 1004, http://dx.doi.org/10.1038/sj.bjc.6605239

Van Hazel GA; Pavlakis N; Goldstein D; Olver IN; Tapner MJ; Price D; Bower GD; Briggs GM; Rossleigh MA; Taylor DJ, 2009, 'Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy', Journal of Clinical Oncology, vol. 27, pp. 4089 - 4095, http://dx.doi.org/10.1200/JCO.2008.20.8116

Underhill C; Bartel R; Goldstein D; Snodgrass H; Begbie S; Yates P; White K; Jong K; Grogan P, 2009, 'Mapping oncology services in regional and rural Australia', Australian Journal of Rural Health, vol. 17, pp. 321 - 329, http://dx.doi.org/10.1111/j.1440-1584.2009.01106.x

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, vol. 45, pp. 393 - 399, http://dx.doi.org/10.1016/j.ejca.2008.09.029

Tan TH; Hemmings C; Stafford-bell M; Robson S; Goldstein D; Yip D, 2009, 'The successful management of two pregnancies with wild type metastatic gastrointestinal stromal tumors', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 187 - 192, http://dx.doi.org/10.1111/j.1743-7563.2009.01225.x

Park SB; Goldstein D; Lin CSY; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of Clinical Oncology, vol. 27, pp. 1243 - 1249, http://dx.doi.org/10.1200/JCO.2008.19.3425

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, vol. 132, pp. 2712 - 2723, http://dx.doi.org/10.1093/brain/awp219

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, vol. 45, pp. 393 - 399

Goldstein D; Van Hazel GA; Pavlakis N, 2009, 'Treatment of 5-Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, vol. 27, pp. 4085 - 4095

Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, vol. 32, pp. 116 - 119

Underhill C; Goldstein D; Gorbounova VA; Biakhov MY; Bazin IS; Granov DA; Hossain AM; Blatter J; Kaiser C; Ma D, 2008, 'A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', Oncology, vol. 73, pp. 9 - 20, http://dx.doi.org/10.1159/000120626

Spry N; Harvey J; MacLeod C; Borg M; Ngan SY; Millar JL; Graham P; Zissiadis Y; Kneebone A; Carroll S, 2008, '3D Radiotherapy Can Be Safely Combined With Sandwich Systemic Gemcitabine Chemotherapy in the Management of Pancreatic Cancer: Factors Influencing Outcome', International Journal of Radiation Oncology Biology Physics, vol. 70, pp. 1438 - 1446, http://dx.doi.org/10.1016/j.ijrobp.2007.08.070

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, vol. 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Pranavan G; Goldstein D; Yip D, 2008, 'Response of Carney's triad-related metastatic gastrointestinal stromal tumor to sunitinib', Asia-Pacific Journal of Clinical Oncology, vol. 4, pp. 170 - 174, http://dx.doi.org/10.1111/j.1743-7563.2008.00182.x

Park SB; Krishnan AV; Lin CSY; Goldstein D; Friedlander M; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry, vol. 15, pp. 3081 - 3094, http://dx.doi.org/10.2174/092986708786848569

Shepherd L; Goldstein D; Olver I; Parle M, 2008, 'Enhancing psychosocial care for people with cancer in rural communities: What can remote counselling offer?', Australian Health Review, vol. 32, pp. 423 - 438, http://dx.doi.org/10.1071/AH080423

Vonlaufen A; Phillips PA; Xu ZH; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Lending a helping hand: Role of pancreatic stellate in pancreatic cancer', Cancer Research, vol. 68, pp. 7707 - 7710

Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, vol. 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1

Bennett B; Goldstein D; Friedlander M; Hickie I; Lloyd A, 2007, 'The Experience of Cancer-Related Fatigue and Chronic Fatigue Syndrome: A Qualitative and Comparative Study', Journal of Pain and Symptom Management, vol. 34, pp. 126 - 135, http://dx.doi.org/10.1016/j.jpainsymman.2006.10.014

Butow PN; Eisenbruch M; Goldstein D; Duggal-Beri P; Jefford M; Schofield P; Girgis A; King M, 2007, 'Unmet needs in Chinese, Greek and arabic speaking cancer patients in Australia', PSYCHO-ONCOLOGY, vol. 16, pp. S77 - S78, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander M; Zalcberg J; White S, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, vol. 6, pp. 578 - 582, http://dx.doi.org/10.3816/CCC.2007.n.025

Goldstein D; Underhill C, 2007, 'Regional cancer services in Australia: Some evidence of improvement but a long way to go', Cancer Forum, vol. 31, pp. 67 - 69

Yang JL; Qu XJ; Hayes VM; Brenner PC; Russell PJ; Goldstein D, 2007, 'Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-α', BJU International, vol. 99, pp. 1539 - 1545, http://dx.doi.org/10.1111/j.1464-410X.2007.06778.x

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, vol. 34, pp. 126 - 135

Goldstein D; Spry N; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Australia EL, 2006, 'Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal rad', J Clin Oncol, vol. 24, pp. 4104, http://www.ncbi.nlm.nih.gov/pubmed/27953934

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online), vol. 3

Goldstein D; Ackland SP; Bell DR; Olver IN; Davis ID; Rosenthal MA; Toner GC; Pinel MC; Byrne M, 2006, 'Phase II study of vinflunine in patients with metastatic renal cell carcinoma', Investigational New Drugs, vol. 24, pp. 429 - 434, http://dx.doi.org/10.1007/s10637-006-6437-0

Shepherd L; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, vol. 32, pp. 453 - 461, http://dx.doi.org/10.1016/j.jpainsymman.2006.05.018

Mok KW; Goldstein D, 2006, 'Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?', Asia-Pacific Journal of Clinical Oncology, vol. 2, pp. 175 - 179, http://dx.doi.org/10.1111/j.1743-7563.2006.00066.x

Mitchell PL; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; White S; Thomson JA; Calrke S, 2006, 'Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity', Clinical Colorectal Cancer, vol. 6, pp. 146 - 151, http://dx.doi.org/10.3816/CCC.2006.n.032

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: A practical case-based approach', Internal Medicine Journal, vol. 36, pp. 367 - 377, http://dx.doi.org/10.1111/j.1445-5994.2006.01077.x

Dalton L; Luxford K; Boyle F; Goldstein D; Underhill C; Yates P, 2006, 'An educational workshop program for rural practitioners to encourage best practice for delivery of systemic adjuvant therapy', Journal of Cancer Education, vol. 21, pp. 35 - 39, http://dx.doi.org/10.1207/s15430154jce2101_12

Underhill CR; Goldstein D; Grogan PB, 2006, 'Inequity in rural cancer survival in Australia is not an insurmountable problem', Medical Journal of Australia, vol. 185, pp. 479 - 480

Goldstein D; Bennett B; Friedlander M; Davenport T; Hickie I; Lloyd A, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: A longitudinal study', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-240

Grimison PS; Chin MT; Harrison ML; Goldstein D, 2006, 'Primary pancreatic lymphoma - Pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-117

Barlow-Stewart K; Soo SY; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Toward cultural competence in cancer genetic counseling and genetics education: Lessons learned from Chinese-Australians', Genetics in Medicine, vol. 8, pp. 24 - 32, http://dx.doi.org/10.1097/01.gim.0000195884.86201.a0

Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2006, 'Oxaliplatin and axonal Na ⁺ channel function in vivo', Clinical Cancer Research, vol. 12, pp. 4481 - 4484, http://dx.doi.org/10.1158/1078-0432.CCR-06-0694

Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, vol. 36, pp. 367 - 377

Van Glabbeke M; Verweij J; Casali PG; Le Cesne A; Hohenberger P; Ray-Coquard I; Schlemmer M; Van Oosterom AT; Goldstein D; Sciot R, 2005, 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian', Journal of Clinical Oncology, vol. 23, pp. 5795 - 5804, http://dx.doi.org/10.1200/JCO.2005.11.601

Marx G; Taylor J; Goldstein D, 2005, 'Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: An Australian experience', Internal Medicine Journal, vol. 35, pp. 34 - 38, http://dx.doi.org/10.1111/j.1445-5994.2004.00749.x

Grimison P; Goldstein D; Schneeweiss J; Murray N, 2005, 'Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms', Internal Medicine Journal, vol. 35, pp. 136 - 137, http://dx.doi.org/10.1111/j.1445-5994.2004.00757.x

Grimison P; Goldstein D; Yeo B, 2005, 'Editor's quiz: GI snapshot. An unusual abdominal mass', Gut, vol. 54, http://dx.doi.org/10.1136/gut.2004.051342

Ngan SYK; Fisher R; Burmeister BH; Mackay J; Goldstein D; Kneebone A; Schache D; Joseph D; McKendrick J; Leong T, 2005, 'Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801)', Diseases of the Colon and Rectum, vol. 48, pp. 1389 - 1396, http://dx.doi.org/10.1007/s10350-005-0032-x

Grimpen F; Yip D; McArthur G; Waring P; Goldstein D; Loughrey M; Beshay V; Chong G, 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, vol. 6, pp. 724 - 727, http://dx.doi.org/10.1016/S1470-2045(05)70321-1

Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, vol. 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6

Goldstein D; Mitchell P; Michael M; Beale P; Friedlander M; Zalcberg J; White S; Clarke S, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, vol. 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426

Goldstein D, 2005, 'The role of chemotherapy in the treatment of pancreatic carcinoma', Australian Prescriber, vol. 28

Yip D; Goldstein D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, vol. 31, pp. 236 - 241, http://dx.doi.org/10.1016/j.ctrv.2005.03.003

Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J, 2005, 'Gastrointestinal stromal tumours: Correlation of ¹⁸ F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response - An AGITG study', Oncology, vol. 69, pp. 326 - 332, http://dx.doi.org/10.1159/000089765

Thewes B; Meiser B; Taylor A; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer', Journal of Clinical Oncology, vol. 23, pp. 5155 - 5165, http://dx.doi.org/10.1200/JCO.2005.07.773

Yeo SS; Meiser B; Barlow-Stewart K; Goldstein D; Tucker K; Eisenbruch M, 2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho-Oncology, vol. 14, pp. 174 - 186, http://dx.doi.org/10.1002/pon.831

Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, vol. 32, pp. 51 - 60, http://dx.doi.org/10.1002/mus.20340

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines', Cancer Letters, vol. 225, pp. 61 - 74, http://dx.doi.org/10.1016/j.canlet.2004.11.041

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines', Oncology, vol. 69, pp. 224 - 238, http://dx.doi.org/10.1159/000088070

Goldstein D; Yip D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, vol. 31, pp. 236 - 241

Glabbeke M; Verweij J; Casali P; Le Cesne A; Hohenberger P; Ray-Coquard I; Goldstein D; Schlemmer M; Van Oosterom AT; Sciot R, 2005, 'Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A Eurpoean Organisation for Research and Treatment of Cancer etc.', Journal of Clinical Oncology, vol. 23, pp. 5795 - 5804

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, vol. 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508

Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G, 2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, vol. 4, http://dx.doi.org/10.1186/1471-2407-4-74

Hughes BGM; Yip D; Chao M; Gibbs P; Carroll S; Goldstein D; Burmeister B; Karapetis C, 2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, vol. 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x

Brown RF; Butow PN; Sharrock MA; Henman M; Boyle F; Goldstein D; Tattersall MHN, 2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, vol. 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x

Loi S; Goldstein D; Clezy K; Milliken ST; Hoy J; Chipman M, 2004, 'Castleman's disease and HIV infection in Australia', HIV Medicine, vol. 5, pp. 157 - 162, http://dx.doi.org/10.1111/j.1468-1293.2004.00204.x

Goldstein D; Carroll S; Apte M; Keogh G, 2004, 'Modern management of pancreatic carcinoma', Internal Medicine Journal, vol. 34, pp. 475 - 481, http://dx.doi.org/10.1111/j.1444-0903.2004.00658.x

Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MHN, 2004, 'Cancer patient preferences for communication of prognosis in the metastatic setting', Journal of Clinical Oncology, vol. 22, pp. 1721 - 1730, http://dx.doi.org/10.1200/JCO.2004.04.095

Bennett B; Goldstein D; Lloyd A; Davenport T; Hickie I, 2004, 'Fatigue and psychological distress - Exploring the relationship in women treated for breast cancer', European Journal of Cancer, vol. 40, pp. 1689 - 1695, http://dx.doi.org/10.1016/j.ejca.2004.03.021

Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, vol. 5, pp. 377 - 384, http://dx.doi.org/10.1111/j.1468-1293.2004.00238.x

Eisenbruch M; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2004, 'Optimising clinical practice in cancer genetics with cultural competence: Lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, vol. 59, pp. 235 - 248, http://dx.doi.org/10.1016/j.socscimed.2003.10.016

Daly EB; Chen G; Sun L; Friedlander M; Goldstein D; Beer DG; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presence or extent of tumor [2]', International Journal of Biological Markers, vol. 19, pp. 170 - 172

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon α', Gut, vol. 53, pp. 123 - 129, http://dx.doi.org/10.1136/gut.53.1.123

Qu XJ; Yang JL; Russell PJ; Goldstein D, 2004, 'Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-α treatment', Journal of Urology, vol. 172, pp. 733 - 738, http://dx.doi.org/10.1097/01.ju.0000130751.83953.55

Apte MV; Park S; Phillips PA; Santucci N; Goldstein D; Kumar RK; Ramm GA; Buchler M; Friess H; McCarroll JA, 2004, 'Desmoplastic reaction in pancreatic cancer: Role of pancreatic stellate cells', Pancreas, vol. 29, pp. 179 - 187, http://dx.doi.org/10.1097/00006676-200410000-00002

Jong KE; Smith DP; Yu XQ; O'Connell DL; Goldstein D; Armstrong BK, 2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, vol. 180, pp. 618 - 622

Shannon JF; Mackenzie-Wood A; Wood G; Goldstein D, 2003, 'Cicatricial pemphigoid in non-Hodgkin's lymphoma [2]', Internal Medicine Journal, vol. 33, pp. 396 - 397, http://dx.doi.org/10.1046/j.1445-5994.2003.t01-1-00430.x

Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, vol. 73, pp. 660 - 662, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x

Senanayake S; Kelly J; Lloyd A; Waliuzzaman Z; Goldstein D; Rawlinson W, 2003, 'Multicentric Castleman's disease treated with antivirals and immunosuppressants', Journal of Medical Virology, vol. 71, pp. 399 - 403, http://dx.doi.org/10.1002/jmv.10500

Marx GM; Boyce A; Goldstein D, 2002, 'Elevated α-foetoprotein and hepatic metastases - It's not always what it seems!', Annals of Oncology, vol. 13, pp. 167 - 169, http://dx.doi.org/10.1093/annonc/mdf015

Goldstein D; Thewes B; Butow P, 2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, vol. 32, pp. 289 - 296, http://dx.doi.org/10.1046/j.1445-5994.2002.00230.x

Harrison ML; Goldstein D, 2002, 'Prolonged survival in a patient with an occult primary small-cell lung cancer and a solitary brain metastasis at diagnosis [1]', Internal Medicine Journal, vol. 32, pp. 621 - 622, http://dx.doi.org/10.1046/j.1445-5994.2002.00285.x

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, vol. 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, vol. 32, pp. 158 - 162

Goldstein D; Margo J, 2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, vol. 25, pp. 121 - 125

Ngan SYK; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D, 2001, 'Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: A Phase II trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology Biology Physics, vol. 50, pp. 883 - 887, http://dx.doi.org/10.1016/S0360-3016(01)01536-X

Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson G; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, vol. 32, pp. 89 - 94, http://dx.doi.org/10.1016/S0169-5002(00)00207-5

Meiser B; Eisenbruch M; Barlow-Stewart K; Tucker K; Steel Z; Goldstein D, 2001, 'Cultural aspects of cancer genetics: Setting a research agenda', Journal of Medical Genetics, vol. 38, pp. 425 - 429

Herz H; Cooke B; Goldstein D, 2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, vol. 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525

Bishop JF; Dewar J; Toner GC; Smith J; Tattersall MHN; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H, 1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, vol. 17, pp. 2355 - 2364

Huang X; Butow PN; Meiser B; Goldstein D, 1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, vol. 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x

Goldstein D; Hertzog P; Tomkinson E; Couldwell D; McCarville S; Parrish S; Cunningham P; Newell M; Owens M; Cooper DA, 1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, vol. 178, pp. 858 - 861, http://dx.doi.org/10.1086/515343

Davis AJ; Goldstein D; Milliken S, 1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, vol. 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x

Newell M; Milliken S; Goldstein D; Lewis C; Boyle M; Dolan G; Ryan S; Cooper DA, 1998, 'A phase II study of liposomal doxorubicin in the treatment of HIV- related Kaposi's sarcoma', Australian and New Zealand Journal of Medicine, vol. 28, pp. 777 - 783, http://dx.doi.org/10.1111/j.1445-5994.1998.tb01553.x

Butow PN; Tattersall MHN; Goldstein D, 1997, 'Communication with cancer patients in culturally diverse societies', Annals of the New York Academy of Sciences, vol. 809, pp. 317 - 329

Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E, 1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', ONCOLOGY, vol. 11, pp. 19 - 23

Pillay P; Goldstein D; Hayman JA; Leyden M, 1997, 'Association of hypercalcemia, PTHrP expression and disease progression in a woman with primary squamous cell carcinoma of the breast', Pathology, vol. 29, pp. 317 - 319, http://dx.doi.org/10.1080/00313029700169195

Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi's sarcoma as an initial and later AIDS associated illness', Annals of Oncology, vol. 8, pp. 871 - 875, http://dx.doi.org/10.1023/A:1008261413274

Joshua DE; Penny R; Matthews JP; Laidlaw CR; Gibson J; Bradstock K; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: A randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, vol. 97, pp. 38 - 45, http://dx.doi.org/10.1046/j.1365-2141.1997.9942643.x

Joshua D; Penny R; Matthews JP; Laidlawcr; Gibson K; Bradstock KF; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive comBination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, pp. 38 - 45

Goldstein D; Bishop J; Dewar J; Tattersall MH; Smith JS; Olver IN; Ackland S; Kennedy I; Toner GC; Gurney H, 1997, 'Paclitaxel as first line treatment for metastatic breast cancer.', Oncology, pp. 17 - 19

Goldstein D; Wolley I; Collett J, 1997, 'Diffuse alveolar damage following a singel adminstration of a cyclophosphamide containing chemotherapy regimen.', Australian and New Zealand Journal of Medicine, pp. 605 - 606

Millar JL; Goldstein D; Gelmon KA, 1996, '5.14 HIV and Kaposi's sarcoma', Medical Journal of Australia, vol. 164, pp. 539 - 542

Boyle MJ; Goldstein DA; Frazer IH; Sculley TB, 1996, 'How HIV promotes malignancies', Medical Journal of Australia, vol. 164, pp. 230 - 232

Dear AE; Goldstein D; Hayman JA, 1996, 'Malignant pulmonary lymphoid disease: Case reports illustrating anatomical pattern of disease as a prognostic marker', Pathology, vol. 28, pp. 20 - 24, http://dx.doi.org/10.1080/00313029600169443

Goldstein D, 1996, 'HIV associated malignancies', Hematology Reviews and Communications, vol. 9, pp. 275 - 283

Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, vol. 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x

Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, vol. 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142

Stricker P; Pryor K; Nicholson T; Goldstein D; Golovsky D; Ferguson R; Nash P; Ehsman S; Rumma J; Mammen G, 1996, 'Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer', Urology, vol. 48, pp. 957 - 962, http://dx.doi.org/10.1016/S0090-4295(96)00375-5

Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS, 1996, 'Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma', British Journal of Cancer, vol. 73, pp. 989 - 994, http://dx.doi.org/10.1038/bjc.1996.193

Newell M; Goldstein D; Milliken S; Lewis C; Hoy J; Thomson B; Cooper D, 1996, 'Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma', Annals of Oncology, vol. 7, pp. 1029 - 1036, http://dx.doi.org/10.1093/oxfordjournals.annonc.a010495

Dear A; Goldstein D; Salem HH, 1995, 'Pulmonary chronic lymphocytic leukemia: Difficulty in establishing a tissue diagnosis', European Journal of Haematology, vol. 54, pp. 130 - 133, http://dx.doi.org/10.1111/j.1600-0609.1995.tb01783.x

Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R, 1995, 'Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing', British Journal of Cancer, vol. 71, pp. 801 - 807, http://dx.doi.org/10.1038/bjc.1995.155

Friedlander M; Lewis C; Goldstein D, 1994, 'Wanted: guidelines for "Palliative" anti-cancer drug use.', Med J Aust, vol. 161, pp. 638, https://www.ncbi.nlm.nih.gov/pubmed/7526139

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, vol. 161, pp. 638 - 639

Kaldor J; Elford J; Grulich A; Goldstein D, 1994, 'HIV AIDS and cancer', Cancer Forum, vol. 18, pp. 3 - 11

Tindall B; Forde S; Goldsten D; Ross MW; Cooper DA, 1994, 'Sexual dysfunction in advanced HIV disease', AIDS Care, vol. 6, pp. 105 - 107, http://dx.doi.org/10.1080/09540129408258030

Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA, 1994, 'Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine', Patient Education and Counseling, vol. 24, pp. 261 - 266, http://dx.doi.org/10.1016/0738-3991(94)90069-8

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand journal of medicine, vol. 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, vol. 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

GOLDSTEIN D; KAUFMANN M, 1992, 'NOVEL APPROACHES TO THE MANAGEMENT OF GYNECOLOGIC MALIGNANCIES - CHAIRMENS PREFACE - PROCEEDINGS OF A SATELLITE SYMPOSIUM HELD IN CAIRNS, AUSTRALIA, ON 22 SEPTEMBER 1991', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 2, pp. 1 - 1, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992KF21500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Goldstein D; Lewis C, 1991, 'Advances in drug delivery and targeting', Current Opinion in Oncology, vol. 3, pp. 1096 - 1104, http://dx.doi.org/10.1097/00001622-199112000-00019

Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z, 1989, 'Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy', Oncology (Switzerland), vol. 46, pp. 105 - 108, http://dx.doi.org/10.1159/000226695

Goldstein D; Kelly R; Ralston M; Penny R; Hayes J, 1987, 'Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma', Medical Oncology and Tumor Pharmacotherapy, vol. 4, pp. 101 - 105, http://dx.doi.org/10.1007/BF02934947

Geczy CL; Ryan J; Walsh J; Goldstein D, 1986, 'Lymphokine‐induced monocyte procoagulant activity is depressed in patients with advanced malignancies', International Journal of Cancer, vol. 37, pp. 677 - 682, http://dx.doi.org/10.1002/ijc.2910370506

Bekaii-Saab T; Goldstein D; Li CP; Okusaka T; O'Neil B; Reni M; Tabernero J; Qin S; Van Cutsem E; Borodyansky L, 2017, 'CanStem111P trial: A phase III study of napabucasin plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, presented at ESMO 19th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 28 June - 01 July 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000405528100362&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', European Pancreatic Club, Toledo, Pancreatology 15(3):S17, presented at European Pancreatic Club, Toledo, Pancreatology 15(3):S17, 01 - 01 June 2015

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', International Association of Pancreatology, Shanghai, Pancreatology, presented at International Association of Pancreatology, Shanghai, Pancreatology, 01 - 01 August 2015

wang X, 2015, 'Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines', 2015 Annual Sarcoma Conference, Brisbane, Australia, presented at 2015 Annual Sarcoma Conference, Brisbane, Australia, 17 - 18 October 2015

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson J; Apte M, 2015, 'Pancreatic Cancer: Stromal Re-programming Offers a Novel Therapeutic Approach', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1407 - 1408, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000233&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Yip S; Pavlakis N; Harvie R; Martin A; Jovanovic L; Hudson A; Thompson JF; Nelson C; Long A; Steer C, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428

Davis ID; Long A; Martin A; Espinoza D; Yip S; Kichenadasse G; Thompson JF; Harrison ML; Lowenthal RM; Pavlakis N, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438

Pothula S; Patel M; Xu Z; Lee A; Goldstein D; Pirola R; Apte M; Wilson JS, 2014, 'The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer', International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, presented at International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, 01 - 01 June 2014

Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2014, 'Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer', Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, presented at Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, 01 - 01 November 2014

Webber K; Bennett BK; Goldstein D; Lloyd AR, 2014, 'Genetic associations of fatigue and other symptom domains after breast cancer treatment: Results from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago, IL, 30 May - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9537

Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Youkhana J; Mccarroll J; Sharbeen G; Erkan M; Liu J; Goldstein D; Phillips PA, 2014, 'Heat shock protein 47 is a potential therapeutic target for the depletion of cancer-promoting stromal cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419602272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Beesley VL; Janda M; Wockner LF; O'Rourke P; Gooden H; Goldstein D; Merrett ND; Wyld DK; Neale RE, 2013, 'PANCREATIC CANCER PATIENT'S MODERATE OR HIGH UNMET SUPPORTIVE CARE NEEDS OVER TIME AND RISK FACTORS OF FUTURE UNMET NEEDS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 105 - 105, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bennett B; Webber K; Goldstein D; Lloyd A, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Amsterdam, NETHERLANDS, pp. S283 - S283, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, NETHERLANDS, 27 September - 01 October 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843602060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Goldstein D, 2013, 'THERAPEUTIC POTENTIAL OF ANGIOGENESIS INHIBITORS FOR GASTRIC', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Sendai, JAPAN, presented at 11th Annual Meeting of the Japanese-Society-of-Medical-Oncology, Sendai, JAPAN, 29 - 31 August 2013, http://dx.doi.org/10.1093/annonc/mdt437.1

Pothula S; Xu Z; Arun S; Goldstein D; Biankin A; Pirola R; Wilson J; Apte M, 2013, 'Hepatocyte Growth Factor Inhibition: A Therapeutic Approach Superior to Gemcitabine in Pancreatic Cancer?', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1377 - 1377, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sharbeen G; Liu J; Mccarroll J; Youkhana J; Teo J; Mccarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken N; Wyld D; Beale PJ; Jefford M; Glasgow AL, 2012, 'Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803861&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803706&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Racadot S; Hammel P; Chibaudel B; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Huguet F, 2012, 'Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, Boston, MA, pp. S322 - S322, presented at 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston, MA, 28 - 31 October 2012, http://dx.doi.org/10.1016/j.ijrobp.2012.07.845

Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802389&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bennett BK; Goldstein D; Friedlander M; Park SB; Kiernan MG, 2011, 'Oxaliplatin-induced Neurotoxicity - Comparing Four Methods of Assessment', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Stockholm, SWEDEN, pp. S234 - S234, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN, 23 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71114-5

Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Stockholm, SWEDEN, pp. S436 - S436, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN, 23 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71792-0

Youkhana J; Liu J; Kiriella N; Yang L; Xu Z; Biankin A; Goldstein D; Wilson J; Apte MV; Phillips PA, 2011, 'Heat shock proteins 27 and 47 inhibit platelet-derived growth factor (PDGF)-induced pancreatic stellate cell proliferation: implication in pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 19 - 19, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Youkhana J; Liu J; Kiriella N; Yang L; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte MV, 2011, 'Heat Shock Proteins 27 and 47 Inhibit Platelet-Derived Growth Factor (PDGF)-Induced Pancreatic Stellate Cell Proliferation: Implication in Pancreatic Cancer Progression', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1365 - 1366, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296398000273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Arun SJ; Xu Z; Fiala-Beer E; Yang L; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 20 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bennett BK; Goldstein D; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Hickie I; Scott E; Rogers N; Lloyd AR, 2010, 'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.605

Fiala-Beer E; Xu Z; Phillips P; Yang L; Goldstein D; Pirola R; Wilson J; Apte M, 2010, 'Role of Pancreatic Stellate Cells in Pancreatic Cancer: The Urokinase Plasminogen Activator System', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1320 - 1320, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Fiala-Beer E; Xu Z; Phillips PA; Yang L; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer: the urokinase plasminogen system', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A75 - A75, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Aldridge L; McGrane J; Butow PN; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Yates P; Connell S, 2010, 'Unmet needs in Chinese (Mandarin and Cantonese), Greek, and Arabic-speaking cancer survivors in Australia', in Psycho-oncology, John Wiley & Sons, New York, pp. 1810 - 1813, 01 January 2010

Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at ., 01 - 01 January 2010

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Chicago, IL, pp. A277 - A277, presented at Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, Chicago, IL, 30 May - 04 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275277201376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Phillips PA; Chow E; Kaplan W; Cowley M; Vonlaufen A; Yang L; Goldstein D; Pirola R; Wilson J; Apte MV, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A333 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Pancreatic stellate cells (stromal cells) migrate with pancreatic cancer cells to distant metastatic sites', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A334 - A335, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Phillips PA; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A334 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2008, 'Early detection of oxaliplatin-induced neurotoxicity: Getting it before it hurts', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.15015

Xu Z; Vonlaufen A; Phillips PA; Fiala-Beer E; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2008, 'PANCREATIC STELLATE CELLS STIMULATE ANGIOGENESIS IN PANCREATIC CANCER AND ACCOMPANY PANCREATIC CANCER CELLS TO DISTANT METASTATIC SITES', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 502 - 503, http://dx.doi.org/10.1097/01.MPA.0000335420.28357.d3

Bennett B; Goldstein D; Friedlander M; Boyle F; De Souza P; Wilken N; Hickie I; Scott E; Lloyd A, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, pp. S36 - S37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Spry N; Harvey J; MacLeod C; Borg M; Ngan S; Millar J; Graham P; Delaney G; Reece W; Goldstein D, 2006, 'Concurrent infusional 5-fluorouracil and 'protocol specific' 3D conformal radiotherapy is effective and safe in combination with 'sandwich' gemcitabine in the management of locally advanced pancreatic', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 21 - 21, presented at Satellite Symposium on New Horizons for Gastric Cancer held in conjunction with the 8th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 29 June 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Joshi S; Vonlaufen A; Xu Z; Daniel B; Qu CF; Kumar RK; Pirola R; Wilson J; Goldstein D; Apte M, 2006, 'Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 472 - 473, http://dx.doi.org/10.1097/00006676-200611000-00123

Goldstein D; Spry N; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MJ; Shapiro J; Iacopetta BJ, 2006, 'Combined modality therapy for pancreatic carcinoma: An australian pancreatic cancer group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI5FI)and 3D conformal radio', in Bhave AB (ed.), Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, Atlanta, Georgia USA, pp. 203s - 203s, presented at 42nd Annual Meeting of the Amercian Society of Clinical Oncology, Atlanta, Georgia USA, 02 - 06 June 2005

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, pp. 266S - 266S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL, 13 - 17 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Joshi SB; Qu CF; Phillips PA; Pirola RC; Wilson JS; Goldstein D; Apte MV, 2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 - 16 November 2005

Goldstein D; Van Hazel GA; Underhill CR; Kotasek D; Harvey JE; Links MR; Shapiro J; Iacopetta BJ; Spry N; Lilly E, 2004, '', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, 01 January 2004

Evans VE; Vockler C; Magnay J; Friedlander N; Lewis CR; Goldstein D; Walsh BR; Holden BA; Willcox MD, 2000, 'Lacryglobin in human tears, a potential marker for cancer metastasis', in Australian and New Zealand Journal of Ophthalmology, Blackwell Science Asia, Sydney, pp. 36 - 36, presented at Australasian Ophthalmic and Visual Sciences Meeting 2000, Sydney, 01 December 2000

Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E, 1997, 'A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results', in Seminars in Oncology

Goldstein D; Davis A; Milliken ST, 1997, 'Long term follow-up of CEOP in the treatment of HIV related NHL.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology, 01 January 1997

Goldstein D; Padigliene A; Law MG; Kaldor JM; Mijch AM; Hoy JF, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology, 01 January 1997

Goldstein D; Milliken ST; Chipman M; Lebon J; Lewis CR; Cooper DA, 1997, 'Dox-SL maintenance therapy after response in AIDS-related Kaposis Sarcoma.', in J. AIDS and Human Retrovirology, J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology, 01 January 1997

Goldstein D; Cooper DA, 1993, 'Current status of clinical trials in HIV disease in Australia', in Journal of Acquired Immune Deficiency Syndromes, pp. S68 - S71

Wang X; Goldstein D; Crowe P; Yang J-L, 2013, 'Mechanisms of gefitinib alone and in combination therapy in soft tissue sarcoma cell lines.', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH, Vol. 12, http://dx.doi.org/10.1158/1535-7163.TARG-13-A113

Wang X; Goldstein D; Crowe P; Yang J, 2013, 'STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth', 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, presented at 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, 14 - 16 February 2013

Wang X; Goldstein D; Crowe P; Yang J, 2012, 'STAT3-targeted therapy on human soft tissue sarcomas', 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, presented at 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, 09 - 11 February 2012

Wang X; Goldstein D; Crowe P; Yang J, 2012, 'Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors', The 103rd Annual Meeting of AACR 2012, presented at The 103rd Annual Meeting of AACR 2012, 31 March - 04 April 2012

Kandula T; Farrar M; Murray J; Goldstein D; Krishnan A; Park S, 2016, '9. Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?', in Clinical Neurophysiology, Elsevier BV, Vol. 127, pp. e13 - e13, http://dx.doi.org/10.1016/j.clinph.2015.11.029

McCrary JM; Park S; Goldstein D, 2016, 'A SYSTEMATIC REVIEW AND DELPHI SURVEY OF ASSESSMENT STRATEGIES FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 128 - 128, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

McCrary JM; Park S; Goldstein D, 2016, 'CLINICIAN AND NURSE REPORTING HABITS FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 129 - 129, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Tempero MA; Cardin DB; Goldstein D; O'Reilly EM; Philip AP; Riess H; Macarulla T; Yung L; Li M; Lu BD, 2016, 'APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.tps473

McNamara MG; Bridgewater JA; Lopes A; Wasan H; Malka D; Jensen HR; Okusaka T; Knox JJ; Wagner AD; Cunningham D, 2016, 'Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.382

Yip S; Harvie R; Martin AJ; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Burnell MJ, 2016, 'Evaluation of circulating VEGF based biomarkers in INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study b', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 34, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 21 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.64

Wege H; Arnold D; Bechstein WO; Bridgewater J; Goldstein D; Jensen LH; Kasper S; Klumpen HJ; Kunzmann V; Lindig U, 2015, 'ADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN COMPARED TO OBSERVATION AFTER CURATIVE INTENT RESECTION OF CHOLANGIOCARCINOMA AND MUSCLE INVASIVE GALLBLADDER CARCINOMA (ACTICCA-1) - A RANDOMIZED,', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, Vol. 62, pp. S845 - S846, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, 22 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)31489-6

Sharbeen G; Liu J; McCarroll J; Limbri L; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sharbeen G; McCarroll J; Liu J; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Wang X; Goldstein D; Crowe P; Yang JL, 2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, Vienna, AUSTRIA, 01 January 2015, http://dx.doi.org/10.1016/S0959-8049(16)31921-9

Stein A; Arnold D; Bechstein WO; Bridgewater JA; Goldstein D; Jensen LH; Kasper S; Kluempen HJ; Kunzmann V; Lindig U, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1): A randomized,', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4140

Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu BD; Von Hoff DD, 2015, 'Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15299

Chan D; Goldstein D; Sjoquist KM; Pavlakis N, 2015, 'Antiangiogenic agents (AAs) in metastatic oesophago-gastric cancer (mOGC): A systematic review and meta-analysis', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15111

Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115

Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L, 2015, 'nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4153

Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J, 2015, 'INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastrointestinal Trials Grou', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4003

Ritchie GE; Fernando M; Goldstein D, 2015, 'RITUXIMAB TO TREAT GEMCITABINE INDUCED HEMOLYTIC URAEMIC SYNDROME IN THREE PATIENTS WITH PANCREATIC ADNENOCARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 11, pp. 63 - 63, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Barbour A; O'Rourke N; Samra JS; Haghighi KS; Kench J; Mitchell J; Pavlakis N; Burge ME; Fawcett J; Gananadha S, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 33, presented at Gastrointestinal Cancers Symposium, San Francisco, CA, 15 - 17 January 2015, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.387

Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP, 2015, 'Correction to "effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers"', in Molecular Pharmaceutics, Vol. 12, pp. 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00092

Webber K; Girgis A; Kaye B; Bonaventura BA; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 31, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Zilliacus E; Meiser B; Taouk M; Watts K; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S, 2013, 'WORKING WITH PATIENTS FROM CULTURALLY AND LINGUISTICALLY DIVERSE BACKGROUNDS: PERSPECTIVES OF ONCOLOGY HEALTH PROFESSIONALS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 9, pp. 130 - 130, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Webber K; Girgis A; Bennett BK; Bonaventura T; Boyle F; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2012, 'CURRENT CARE AND NEEDS OF ADULT CANCER SURVIVORS - A CROSS-SECTIONAL SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 356 - 357, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802650&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sze M; Butow PN; King M; Goldstein D; Jefford M; Girgis A; Eisenbruch M; Bell M; Vaccaro L; Dong R, 2011, 'Cancer in a country not your own: Illness perceptions and distress in immigrant versus native-born cancer patients', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 81 - 81, 01 January 2011

Butow PN; Lobb EA; Schofield PR; Goldstein D; Eisenbruch M; Girgis A; Jefford M; King M; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse (CALD) backgrounds: the interpreter perspective', in Psycho-oncology, John Wiley & Sons, New York, pp. 46 - 46, 01 January 2009

Aldridge L; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M, 2009, 'Unmet needs in Chinese, Greek, Arabic, and English-speaking cancer patients in New South Wales', in Psycho-oncology, John Wiley & Sons, New York, pp. 117 - 117, 01 January 2009

Butow PN; Lobb E; Schofield PR; Jefford M; Goldstein D; King M; Eisenbruch M; Girgis A; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse backgrounds – the interpreters’ perceptions of roles, challenges, and support needs', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 207 - 207, 01 January 2009

Aldridge L; McGrane J; Butow PN; Goldstein D; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Duggal-beri P, 2009, 'Unmet needs in Chinese, Greek, and Arabic-speaking cancer patients in New South Wales', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 221 - 221, 01 January 2009

Butow P; Girgis A; Goldstein D; Eisenbruch M; Schofield P; Jefford M; King M; Duggal-Beri P; Sze M; Mikhail M, 2008, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, Vol. 17, pp. S280 - S280, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200539&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow P; Girgis A; Goldstein D; Eisenbruch M; Schofield P; Jefford M; King M; Duggal-Beri P; Mikhail M; Sze M, 2008, 'Unmet needs in Chinese, Greek and Arabic speaking cancer patients in Australia', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, Vol. 17, pp. S7 - S7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E, 2008, 'Conducting research with culturally and linguistically diversre cancer patients: methodological issues', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 40 - 40, 01 January 2008

Sze M; Duggal-beri P; Butow PN; Mikhail M; Eisenbruch M; Goldstein D; Schofield PR; Jefford M; King M; Girgis A, 2007, 'Low psychological service utilisation in cancer – does it mean CALD patients cope better', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A96 - A96, 01 January 2007

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Psychological morbidity or unmet needs of cancer patients from culturally and linguistically diverse (CALD) backgrounds', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A67 - A67, 01 January 2007

Duggal-beri P; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR, 2007, 'Barriers to research with cancer patients from culturally and linguistically diverse (CALD) communities in Australia', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. A95 - A96, 01 January 2007